FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Sandoz Inc.'s benazepril hydrochloride and hydrochlorothiazide fixed-dose combination (ANDA 076631).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Benazepril hydrochloride and hydrochlorothiazide (Benazepril hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)